R1	AND Arg1:T1 Arg2:T2	
R2	Has_value Arg1:T3 Arg2:T4	
R3	AND Arg1:T3 Arg2:T1	
R4	Has_negation Arg1:T7 Arg2:T9	
R5	AND Arg1:T8 Arg2:T7	
R6	Has_qualifier Arg1:T12 Arg2:T11	
R7	Has_negation Arg1:T12 Arg2:T10	
R8	Has_temporal Arg1:T12 Arg2:T13	
*	OR T16 T14 T15
T1	Condition 38 48	depression
T2	Drug 97 107	medication
T3	Measurement 180 185	PHQ-9
T4	Value 153 172	score of 10 or more
T5	Non-representable 231 706	Some practices utilize the PHQ-2 and PHQ-9 are part of routine screening for depression. If the tests are performed routinely, they do not need to be repeated for study eligibility, and may be performed prior to informed consent for this study. If, however, the PHQ-9 is not routinely performed, informed consent must be performed prior to administration. Patients with a score below 10 will be considered screen failures and will not be enrolled or offered the MYnd testing.
T6	Condition 722 735;745 755	non-psychotic conditions
T7	Drug 798 808	medication
T8	Condition 829 849	behavioral illnesses
T9	Negation 819 824	naïve
T10	Negation 858 860	no
T11	Qualifier 861 867	active
T12	Drug 868 878	medication
T13	Temporal 890 930	for at least 1 month prior to enrollment
T14	Drug 1006 1021	benzodiazepines
T15	Drug 1026 1029	THC
T16	Drug 994 1004	stimulants
T17	Non-representable 774 1103	Patients must be either medication treatment naïve for behavioral illnesses or have no active medication treatments for at least 1 month prior to enrollment. Prohibited medications at the time of enrollment will include stimulants, benzodiazepines and THC. Prior therapy with these agents is permitted with a washout of >30 days.
T18	Non-query-able 1105 1371	Patients must have private medical insurance coverage through Horizon Blue Cross Blue Shield. This is limited to insured commercial members, including HMO, and excluding, for the avoidance of doubt, members of self-insured customers or Medicare or Medicaid programs.
